Approval · Notice of Compliance 548 · 2002
RATIO-FLUNISOLIDE: Notice of Compliance 548
Issued May 1, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 548
- Date
- May 1, 2002
- Company
- Ratiopharm Inc.Ulm, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in manufacturer and product name
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RATIO-FLUNISOLIDE | 00878790 | Cancelled Post Market |
Medicinal ingredients
- FLUNISOLIDE 25 MCG per ACT